Drugs

Category / Pharmaceuticals & Biotech / Drugs

Prana's PBT2 Clinical Trials Cited as Most Advanced in Addressing Neurodegeneration From the Metal Equilibrium Perspective

MELBOURNE, AUSTRALIA: ...

Sirona Biochem Hires Ray Matthews & Associates

VANCOUVER, BRITISH COLUMBIA: ...

Threshold Pharmaceuticals Announces Presentation and Webcast at UBS Global Life Sciences Conference

SOUTH SAN FRANCISCO, CA: ...

SciClone Announces China Government-Mandated ZADAXIN(R) Price Reduction; Anticipates Minimal Impact on Revenue and Margins

FOSTER CITY, CA: ...

Biota and Nabi Announce Revised Merger Terms

MELBOURNE, AUSTRALIA: ...

Titan Pharmaceuticals Announces $4.25 Million Stock Purchase and Option Agreement

SOUTH SAN FRANCISCO, CA: Strategic Investment in Titan Secures Exclusive Option for Probuphine Commercial Rights ...

Sunshine Heart Appoints John Erb to Chairman of the Board

EDEN PRAIRIE, MN and SYDNEY, AUSTRALIA: ...

Xylitol Canada Inc. Announces Appointment of New Director

TORONTO, ONTARIO: President of Mascoma Alberta Drayton Valley Limited To Join Xylitol Canada Board ...

SciClone Announces Management Transitions in China Operations

FOSTER CITY, CA: ...

Gemoscan Canada Announces Unsecured Loans and Issuance of Bonus Shares

TORONTO, ONTARIO: ...

TONIX Pharmaceuticals' CEO Discusses the Company's New Treatment for Fibromyalgia on News-Medical.net

NEW YORK, NY: New Drug Aims to Reduce Pain by Improving Sleep Quality ...

Sarepta Therapeutics Awarded $3.9 Million Contract by U.S. Government to Evaluate Feasibility of an Alternate Route of Administration of Its Lead Therapeutic Candidate for Treatment of Marburg Virus

CAMBRIDGE, MA: ...

Sunshine Heart Submits Investigational Device Exemption to FDA for C-Pulse(R) System Pivotal Trial

EDEN PRAIRIE, MN and SYDNEY, AUSTRALIA: ...

Genetic Technologies Files Patent Infringement Suit Against Reproductive Genetics Institute Inc. in USA

MELBOURNE, AUSTRALIA: ...

SciClone Pharmaceuticals to Present at Investor Conferences in September 2012

FOSTER CITY, CA: ...

Gemoscan Canada Announces Closing of Convertible Debenture Financing

TORONTO, ONTARIO: ...

Sunshine Heart Announces Closing of Public Offering of Common Stock

EDEN PRAIRIE, MN and SYDNEY, AUSTRALIA: ...

Gemoscan Canada, Inc.: Diet and Wellness Management Now Even Easier With Hemocode(TM) Lite at Rexall(TM) and Rexall Pharma Plus(TM)

TORONTO, ONTARIO: ...

NuPathe Announces Second Quarter 2012 Financial Results and Operational Highlights

CONSHOHOCKEN, PA: Migraine Patch NDA Resubmission Accepted for Filing by FDA PDUFA Date of January 17, 2013 ...

Grand Slam Asset Management, LLC Writes Letter to Taro Pharmaceutical Industries LTD. (Taro) Shareholders Regarding Sun Pharmaceutical Industries Offer to Purchase the Remaining Outstanding Shares of Taro for an Inadequate Purchase Price

FORT LEE, NJ: ...

Page 50 von 64: 1 « .. 49 50 51 52 53 54 55 56 57 58 .. » 64

All members:	10 591
Register today:	0
Register yesterday:	0
Members online:	0
Guests online:	152

Drugs

Category / Pharmaceuticals & Biotech / Drugs

Prana's PBT2 Clinical Trials Cited as Most Advanced in Addressing Neurodegeneration From the Metal Equilibrium Perspective

Sirona Biochem Hires Ray Matthews & Associates

Threshold Pharmaceuticals Announces Presentation and Webcast at UBS Global Life Sciences Conference

SciClone Announces China Government-Mandated ZADAXIN(R) Price Reduction; Anticipates Minimal Impact on Revenue and Margins

Biota and Nabi Announce Revised Merger Terms

Titan Pharmaceuticals Announces $4.25 Million Stock Purchase and Option Agreement

Sunshine Heart Appoints John Erb to Chairman of the Board

Xylitol Canada Inc. Announces Appointment of New Director

SciClone Announces Management Transitions in China Operations

Gemoscan Canada Announces Unsecured Loans and Issuance of Bonus Shares

TONIX Pharmaceuticals' CEO Discusses the Company's New Treatment for Fibromyalgia on News-Medical.net

Sarepta Therapeutics Awarded $3.9 Million Contract by U.S. Government to Evaluate Feasibility of an Alternate Route of Administration of Its Lead Therapeutic Candidate for Treatment of Marburg Virus

Sunshine Heart Submits Investigational Device Exemption to FDA for C-Pulse(R) System Pivotal Trial

Genetic Technologies Files Patent Infringement Suit Against Reproductive Genetics Institute Inc. in USA

SciClone Pharmaceuticals to Present at Investor Conferences in September 2012

Gemoscan Canada Announces Closing of Convertible Debenture Financing

Sunshine Heart Announces Closing of Public Offering of Common Stock

Gemoscan Canada, Inc.: Diet and Wellness Management Now Even Easier With Hemocode(TM) Lite at Rexall(TM) and Rexall Pharma Plus(TM)

NuPathe Announces Second Quarter 2012 Financial Results and Operational Highlights

Grand Slam Asset Management, LLC Writes Letter to Taro Pharmaceutical Industries LTD. (Taro) Shareholders Regarding Sun Pharmaceutical Industries Offer to Purchase the Remaining Outstanding Shares of Taro for an Inadequate Purchase Price

Service Menu

New here

Who is online